Article info
Therapeutics
Randomised controlled trial
Treatment with the probiotic VSL#3 as an adjunctive therapy in relapsing mild-to-moderate ulcerative colitis significantly reduces ulcerative colitis disease activity
- Correspondence to Hien Q Huynh
Aberhart Centre Room 9219, 11402 University Avenue NW, Edmonton, AB T6G 2J3, Canada; hien.huynh{at}ualberta.ca
Citation
Treatment with the probiotic VSL#3 as an adjunctive therapy in relapsing mild-to-moderate ulcerative colitis significantly reduces ulcerative colitis disease activity
Publication history
- First published February 24, 2011.
Online issue publication
July 19, 2011
Article Versions
- Previous version (24 February 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions